CLDF Title
Home | Contact Us | Bookmark
 
 
About CLDF Centers of Educational Expertise
 
Back Substance Use Disorder Centers of Educational Expertise  
Banner
 
Jonathan Tobin
Jonathan Tobin, PhD, is the current President/CEO of Clinical Director's Network, which is a Practice-based Research Network dedicated to conducting primary care-based comparative effectiveness research in medically underserved communities.  More
 
  CME and Independent Education  
 
   
 
  Physician Resources 
 
 
  My Publications More  
 
  Changes in experiences with discrimination across pregnancy and postpartum: age differences and consequences for mental health.
 
  Maternal experiences with everyday discrimination and infant birth weight: a test of mediators and moderators among young, urban women of color.
 
  The counseling African Americans to Control Hypertension (CAATCH) Trial: baseline demographic, clinical, psychosocial, and behavioral characteristics.
 
  Translation of a comprehensive health behavior intervention for women living with HIV: the SMART/EST Women's Program.
 
  Community health centers and community development financial institutions: joining forces to address determinants of health.
 
 
 
  Institution Information
Clinical Directors Network, Inc. (CDN) is a not-for-profit clinician membership organization, practice-based research network (PBRN), and clinician training organization, founded to provide peer-initiated activities for clinicians practicing in low income, minority, and other underserved communities. CDN’s overall goal is to translate clinical research into clinical practice for the enhancement of health equity and improvement of public health.
More
 
 
Institution Link  
 
     
  Journal Abstracts  
  Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C  
     
  Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world  
     
  The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing  
     
  Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy  
     
  A Risk Score to Predict the Development of Hepatic Encephalopathy in a Population-Based Cohort of Patients with Cirrhosis  
     
  Treatment options after sorafenib failure in patients with hepatocellular carcinoma  
     
  View All Articles  
     
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.